CancerIQ, a platform powering early cancer detection and prevention across broad patient populations, closed a $14 million Series B financing round co-led by Merck Global Health Innovation Fund and Amgen Ventures. McKesson Ventures, OSF Ventures (the investment arm of OSF HealthCare, a current CancerIQ customer), as well as CancerIQ’s Series A lead investor, HealthX Ventures, also participated in the round. Read more.
Related Posts
Ascend Capital Partners Invests in 2 NY Practices
The investments involved a pediatric care provider and a medical practice administration.
January 30, 2023
Planet DDS Receives ‘Significant’ Investment from Aquiline Capital Partners
Planet DDS serves over 10,000 practices in North America with over 60,000 users
June 1, 2022
MindMaze Scores $125M for Rehab Treatment
AlbaCore Capital Group made the investment.
October 11, 2021